Abstract
Current treatment options for moderate to severe symptomatic lumbar degenerative disc disease include fusion or conservative therapy. The use of autogenous BMC may provide a nonsurgical option for this condition. This is the first report of the safety and feasibility for using autogenous BMC in treating lumbar DDD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
